Foley Partner Antoinette Konski was quoted in an article that appeared in Drug Discovery News on September 2, 2011 titled “Stem Cell Case is Dismissed.” Konski discusses a federal judge’s dismissal of a case seeking to end government funding for human embryonic stem cell research (hESC). She summarizes the decision as a validation of the National Institute of Health’s guidelines regarding stem cell research, adding that it removed a great deal of uncertainty around federal funding of hESC.
Click here to read the complete article.
People
Related News
July 21, 2025
In the News
Nicholas O'Keefe Assesses 'Golden Share' in US Steel Deal
Foley & Lardner LLP partner Nicholas O'Keefe commented on the 'golden share' arrangement included as part of the approval of Nippon Steel's acquisition of U.S. Steel in Agenda, a Financial Times publication.
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."